This is filed to report thrombus.It was reported that this was a mitraclip procedure to treat tricuspid regurgitation (tr) with a grade of 4+.The clip delivery system (cds) was inserted; however, before the clip exited the steerable guide catheter (sgc), a large thrombus was noticed on the tip of the sgc.It was noted that the activated clotting time (act) remain above 250 throughout the procedure.The cds was removed; however, once the clip was removed, thrombus was noticed all around the clip.Aspiration was them performed, but it was then noted that the sgc had thrombus inside the clear chamber.A 16fr sheath was inserted and additional heparin was administered while removing the sgc.The thrombus had been resolved; therefore, a new sgc and cds were inserted without issues.The clip was successfully implanted, reducing tr to a grade of 1-2.There was no clinically significant delay in the procedure.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.It should be noted that the mitraclip instructions for use (ifu) states: the mitraclip g4 system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation.Based on the information reviewed, the reported off-label use of the device was associated with the procedure being performed on the tricuspid valve; however, in this case, it cannot be determined if the off-label use contributed to the reported thrombus.A cause for the thrombus could not be determined in this case; however, thrombosis is listed in the mitraclip ifu as a known possible complication associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design or labeling.
|